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DISCUSSION
Dr Kevin G. Burnand (London, England). You obviously
had more people who were excluded from the study than actually
took part. What you didn’t tell us was the age of these patients. You
visited the ulcer clinic at St. Thomas’s, and I wondered how many
of our 80-year-old female patients would be appropriate for your
exercise program?
Dr Frank T. Padberg. Some of the patients I saw in your
clinic would indeed not have been any more eligible than some of
those we excluded from ours.
The average age was a uniform 70.
Some of the patients excluded were reported at this meeting
last year. The morbidly obese group was excluded because they had
no anatomic evidence of venous disease; although they exhibited
skin changes and ulceration, duplex scans and results of air pleth-
ysmography were normal.
Dr Thomas W. Wakefield (Ann Arbor, Mich). Frank, this
was a very nice study. I have one question.
When you did the APG studies, were the patients wearing
stockings or not wearing stockings? We have seen differences in
APG results whether or not the patients are wearing their stockings
at the time of the study.
Dr Padberg. We uniformly requested that they remove their
stockings for these studies; that way we could compare the baseline
values that were achieved before they received stockings with those
that we achieved with the therapeutic intervals.
Dr Paul Perkowski (Phoenix, Ariz). I have two questions.
Number one, do you have any information on the clinical
significance of this? What percentage of patients healed their ulcers
or had freedom from recurrence of ulcers?
And the second question is, what do you think is the patho-
physiology of this exercise program? Since we know the primary
pathology is valvular incompetence, how do you think this exercise
helps with that?
Dr Padberg. Let me take the second one first. There is
evidence of direct muscle damage in patients with CVI, which is
referenced in the text. Even though the muscle is damaged, we
presume that it can still be conditioned to improve strength and
that the calf muscle pump may compensate to some extent for
reflux. We reported several years ago a sensory deficit, which was
also associated with chronic venous insufficiency in these patients.
As regards the clinical significance, we didn’t ask that question
specifically. Our outcome variables were hemodynamic changes or
muscle strengthening. We assess healing of ulceration as a primary
outcome variable and did not expect to achieve healing as a result
of this treatment option. We were really only looking for whether
or not we could make a difference in terms of either hemodynamics
or exercise strengthening. There is obviously potential for further
study, and long-term follow-up will be required to determine the
value of therapy as an adjunctive mechanism to maintain limbs in the
healed state.
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